| Current status of renal replacement therapy in Turkey: A summary of Turkish Society of Nephrology 2009 annual registry report | Mehmet Rıza ALTIPARMAK, Gültekin SÜLEYMANLAR, Kamil SERDENGEÇTİ, Nurhan SEYAHİ | 1–6 |
| Üremik kaşıntı | Mehmet KOÇ, Ebru AŞICIOĞLU, Çetin ÖZENER, Arzu KAHVECİ | 7–13 |
| New options for old diseases: Aquaretics (vasopressin receptor antagonists) | Gülçin KANTARCI, Gökçe DEMİRAN | 14–18 |
| Relationship between circadian rhythm of blood pressure and bone mineral density in postmenopausal women | Mehmet KANBAY, Ayşe ÇARLIOĞLU, Ali AKÇAY, Faruk TURGUT, Ebru UZ | 19–25 |
| Effects of biocompatible solutions on residual renal functions in peritoneal dialysis patients: A prospective observational study | Mehmet KÜÇÜK, Zeki AYDIN, Rümeyza KAZANCIOĞLU, Ümit AVŞAR, Sami UZUN, Vedat ÇELİK, Ümmü Zeynep AVŞAR, Mustafa YENİGÜN, Meltem GÜRSU, Savaş ÖZTÜRK | 26–31 |
| Relation between circadian rhythm of blood pressure and serum uric acid and body mass index | Mehmet KANBAY, Mustafa KÖROĞLU, Ali AKÇAY, Faruk TURGUT, Ayşe IŞIK | 32–37 |
| Tip 2 diyabet hastalarında bilişsel işlevler ve idrar albumin atılımı arasındaki ilişki | Barış AFŞAR, Rengin ELSÜRER, Tayfun EYİLETEN | 38–45 |
| Octreotide may prevent ultrafiltration failure in experimental peritonitis model | Can DUMAN, Fehmi AKÇİÇEK, Soner DUMAN, Ender HÜR, Bilgin ARDA, Sait ŞEN, Savaş SİPAHİ, Ali BAŞÇI, Devrim BOZKURT, Muhittin ERTİLAV | 46–52 |
| Efficacy of tacrolimus in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatments | İbrahim AKDAĞ, Serdar KAHVECİOĞLU, Cuma Bülent GÜL, Kamil DİLEK, Mehmet USTA, Mustafa GÜLLÜLÜ, Mustafa YURTKURAN, Mahmut YAVUZ, Alparslan ERSOY | 53–57 |
| Kronik böbrek yetmezliği hastalarında koroner arter hastalığı ciddiyeti ile “asymmetrical dimethylarginine” arasındaki ilişki | Ferah ARMUTÇU, Yusuf SELCOKİ, Mehmet KANBAY, Mustafa İKİZEK, Beyhan ERYONUCU, Murat AYDIN | 58–64 |
| Intravenous Iron Treatment in patients with chronic renal disease, oxidative stress and the effect of N-acetylcysteine |